Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HN-CLEAR: Head and Neck Consensus Language for Ease and Reproducibility, a Multidisciplinary Consensus Mechanism for Head and Neck Pathology.
Gupta R, Bal M, Bishop JA, Hunter KD, Magliocca K, Seethala RR, Thompson LDR, Weinreb I, Angelos P, Beadle B, Bell RB, Clark JR, Ferris R, Huang SH, Hayes DN, Ladwa R, Yang J, Cipriani NA, Nelson BL, Sadow PM, Lewis JS. Gupta R, et al. Among authors: ladwa r. Head Neck Pathol. 2023 Sep;17(3):877-880. doi: 10.1007/s12105-023-01570-w. Epub 2023 Jul 24. Head Neck Pathol. 2023. PMID: 37486534 Free PMC article. No abstract available.
Efficacy and safety of cosibelimab, an anti-PD-L1 antibody, in metastatic cutaneous squamous cell carcinoma.
Clingan P, Ladwa R, Brungs D, Harris DL, McGrath M, Arnold S, Coward J, Fourie S, Kurochkin A, Malan DR, Mant A, Sharma V, Shue H, Tazbirkova A, Berciano-Guerrero MA, Charoentum C, Dalle S, Dechaphunkul A, Dudnichenko O, Koralewski P, Lugowska I, Montaudié H, Muñoz-Couselo E, Sriuranpong V, Oliviero J, Desai J. Clingan P, et al. Among authors: ladwa r. J Immunother Cancer. 2023 Oct;11(10):e007637. doi: 10.1136/jitc-2023-007637. J Immunother Cancer. 2023. PMID: 37848259 Free PMC article.
Targeting BRAF mutations in non-small cell lung cancer.
O'Leary CG, Andelkovic V, Ladwa R, Pavlakis N, Zhou C, Hirsch F, Richard D, O'Byrne K. O'Leary CG, et al. Among authors: ladwa r. Transl Lung Cancer Res. 2019 Dec;8(6):1119-1124. doi: 10.21037/tlcr.2019.10.22. Transl Lung Cancer Res. 2019. PMID: 32010589 Free PMC article. Review.
Understanding the tumor microenvironment for effective immunotherapy.
Sadeghi Rad H, Monkman J, Warkiani ME, Ladwa R, O'Byrne K, Rezaei N, Kulasinghe A. Sadeghi Rad H, et al. Among authors: ladwa r. Med Res Rev. 2021 May;41(3):1474-1498. doi: 10.1002/med.21765. Epub 2020 Dec 4. Med Res Rev. 2021. PMID: 33277742 Free PMC article. Review.
The Role of Circulating Biomarkers in Lung Cancer.
Herath S, Sadeghi Rad H, Radfar P, Ladwa R, Warkiani M, O'Byrne K, Kulasinghe A. Herath S, et al. Among authors: ladwa r. Front Oncol. 2022 Jan 21;11:801269. doi: 10.3389/fonc.2021.801269. eCollection 2021. Front Oncol. 2022. PMID: 35127511 Free PMC article. Review.
Immune Checkpoint Inhibitors in Cancer Therapy.
Shiravand Y, Khodadadi F, Kashani SMA, Hosseini-Fard SR, Hosseini S, Sadeghirad H, Ladwa R, O'Byrne K, Kulasinghe A. Shiravand Y, et al. Among authors: ladwa r. Curr Oncol. 2022 Apr 24;29(5):3044-3060. doi: 10.3390/curroncol29050247. Curr Oncol. 2022. PMID: 35621637 Free PMC article. Review.
83 results